1887

Abstract

A variety of cell lines were infected with replication-defective recombinant retroviruses in the presence of stavudine (d4T). Cells which were infected despite the presence of d4T were isolated and subjected to infection with other retroviruses [replication-competent human immunodeficiency virus (HIV), replication-defective HIV or replication-defective recombinant murine retroviruses]. Each of the host cell types tested had a small subset of cells that were infected with HIV or murine retroviruses in the presence of d4T. Some of these infected cells could be infected repeatedly at high efficiency in the presence of d4T. This phenotype of ‘persistent refractoriness’ to the antiviral effects of d4T could be overcome by the addition of 5-fluoro-2-deoxyuridine (floxuridine) to d4T. The d4T–floxuridine combination also had potent antiretroviral effects in primary blood mononuclear cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-9-2361
1999-09-01
2019-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/9/0802361a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-9-2361&mimeType=html&fmt=ahah

References

  1. Ahluwalia, G. S., Gao, W. Y., Mitsuya, H. & Johns, D. G. ( 1996; ). 2′,3′-Didehydro-3′-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5′-triphosphate biosynthesis. Molecular Pharmacology 50, 160-165.
    [Google Scholar]
  2. Finzi, D. & Siciliano, R. F. ( 1998; ). Viral dynamics in HIV-1 infection. Cell 93, 665-671.[CrossRef]
    [Google Scholar]
  3. Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentin, F. T., Jonas, L. & Meibohm, A. ( 1997; ). Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency infection and prior antiretroviral therapy. New England Journal of Medicine 337, 734-739.[CrossRef]
    [Google Scholar]
  4. Havlir, D. & Richman, D. D. ( 1994; ). Viral dynamics of HIV: implications for drug development and therapeutic strategies. Annals of Internal Medicine 124, 984-989.
    [Google Scholar]
  5. Havlir, D. V., Gamst, A., Eastman, S. & Richman, D. D. ( 1996; ). Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. Journal of Virology 70, 7894-7899.
    [Google Scholar]
  6. Lacey, S. F. & Larder, B. A. ( 1994; ). Novel mutation (V75T) in human immunodeficiency virus type I reverse transcriptase confers resistance to 2′,3′-didehydro-2′,3′-dideoxythymidine in cell culture. Antimicrobial Agents & Chemotherapy 38, 1428-1432.[CrossRef]
    [Google Scholar]
  7. Lin, P. F., Samanta, H., Rose, R. E., Patick, A. K., Trimble, J., Bechtold, C. M., Revie, D. R., Khan, N. C., Federici, M. E., Li, H. & Colonno, R. J. ( 1994; ). Genotypic and phenotypic analysis of human immunodeficiency virus type I isolates from patients on prolonged stavudine therapy. Journal of Infectious Diseases 170, 1157-1164.[CrossRef]
    [Google Scholar]
  8. Loveday, C., Kaye, S., Tenant-Flowers, M., Semple, M., Ayliffe, U., Weller, I. D. & Tedder, R. S. ( 1995; ). HIV-1 RNA serum load and resistant viral genotypes during early zidovudine therapy. Lancet 345, 820-825.[CrossRef]
    [Google Scholar]
  9. Medina, D. J., Tung, P. P., Lerner-Tung, M. B., Nelson, C. J., Mellors, J. W. & Strair, R. K. ( 1995; ). Sanctuary growth of human immunodeficiency virus in the presence of 3′-azido-3′-deoxythymidine (AZT). Journal of Virology 69, 1606-1611.
    [Google Scholar]
  10. Medina, D. J., Tung, P. P., Sathya, B. & Strair, R. K. ( 1996; ). Use of floxuridine to modulate the antiviral activity of zidovudine. AIDS Research and Human Retroviruses 12, 965-968.[CrossRef]
    [Google Scholar]
  11. Medina, D. J., Tung, P. P., Nelson, C. J., Sathya, B., Casareale, D. & Strair, R. K. ( 1998; ). Characterization and use of a recombinant retroviral system for the analysis of drug resistant HIV. Journal of Virological Methods 71, 169-176.[CrossRef]
    [Google Scholar]
  12. Miller, A. D. & Rosman, G. T. ( 1989; ). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-990.
    [Google Scholar]
  13. Mosman, T. ( 1983; ). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55-63.[CrossRef]
    [Google Scholar]
  14. Najera, I., Holquin, A., Quinones-Mateu, M. E., Munoz-Fernandez, M. A., Najera, R., Lopez-Galindez, C. & Domingo, E. ( 1995; ). Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. Journal of Virology 69, 23-31.
    [Google Scholar]
  15. Page, K. A., Landau, N. & Littman, D. R. ( 1990; ). Construction and use of a human immunodeficiency virus vector for analysis of viral infectivity. Journal of Virology 64, 5270-5276.
    [Google Scholar]
  16. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. ( 1996; ). HIV-1 dynamics in vivo: virion clearance rate, infected cell life span, viral generation time. Science 271, 1582-1586.[CrossRef]
    [Google Scholar]
  17. Reed, L. J. & Muench, H. ( 1938; ). A simple method for estimating fifty percent end points. American Journal of Hygiene 27, 493-496.
    [Google Scholar]
  18. Strair, R. K., Nelson, C. J. & Mellors, J. W. ( 1991; ). Use of recombinant retroviruses to characterize the activity of antiretroviral compounds. Journal of Virology 65, 6339-6342.
    [Google Scholar]
  19. Strair, R. K., Medina, D. J., Nelson, C. J., Graubert, T. & Mellors, J. W. ( 1993; ). Recombinant retroviral systems for the analysis of drug-resistant HIV. Nucleic Acids Research 21, 4836-4842.[CrossRef]
    [Google Scholar]
  20. Wei, X., Ghosh, S. K., Taylor, M. V., Johnson, V. A., Emini, E. A., Deutch, P., Lifson, J. D., Bonhoeffer, M., Nowak, A., Hahn, B. H., Saag, M. S. & Shaw, G. M. ( 1995; ). Viral dynamics in HIV-1 infection. Nature 373, 117-122.[CrossRef]
    [Google Scholar]
  21. Willey, R. L., Smith, D. H., Lasky, L. A., Theodore, T. S., Earl, P. L., Moss, P., Caponi, D. J. & Martin, M. A. ( 1988; ). In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. Journal of Virology 62, 139-147.
    [Google Scholar]
  22. Zhang, H., Bagasra, O., Nikura, M., Poiesz, B. J. & Pomerantz, R. J. ( 1994; ). Intravirion reverse transcripts in the peripheral blood plasma of human immunodeficiency virus type-1 infected individuals. Journal of Virology 68, 7591-7597.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-9-2361
Loading
/content/journal/jgv/10.1099/0022-1317-80-9-2361
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error